Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2013
12/04/2013CN103421007A Preparation method for levo-praziquantel
12/04/2013CN103421006A 2, 3, 5, 7-tetrasubstituted dihydro-pyrazolo piperidine derivative and preparation method and application thereof
12/04/2013CN103421005A Acetylene derivative capable of resisting activity of tumor
12/04/2013CN103421004A 5-azaindole preparation method
12/04/2013CN103420991A Pyrrolidine derivative used as hepatitis c inhibitor and application thereof in medicine
12/04/2013CN103420988A Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/04/2013CN103420977A Acetylene derivative with anti-tumor activity
12/04/2013CN102391309B Ruthenium coordination compound based on unit containing naphthalimide and synthesis method thereof
12/04/2013CN102295643B 2-(pyridin-2-ylamino)-pyrido[2,3d]pyrimidin-7-ones
12/04/2013CN102190673B Rare earth/ionic liquid luminescent material
12/04/2013CN102115472B 3-(2-pyrromethene)azaindoline-2-one derivatives and preparation method and application thereof
12/04/2013CN101848910B 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
12/04/2013CN101351203B Use of pyrroloquinoline compounds to kill clinically latent microorganisms
12/04/2013CN101331132B [ (1H- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenrative disorders
12/03/2013US8598360 Apoptosis signal-regulating kinase inhibitors
12/03/2013US8598342 Methods and compounds for antimicrobial intervention
12/03/2013US8598217 Imidazole derivatives and their use as modulators of cyclin dependent kinases
12/03/2013US8598193 Polycyclic agents for the treatment of respiratory syncytial virus infections
12/03/2013US8598192 Hydroxylamine substituted imidazoquinolines
12/03/2013US8598190 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
12/03/2013US8598171 Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders
12/03/2013US8598167 Substituted 6,5-fused bicyclic heteroaryl compounds
12/03/2013US8598154 Pyridyl-amine fused azadecalin modulators
12/03/2013CA2691917C Crystalline pyridazine compound
12/03/2013CA2611529C Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
12/03/2013CA2611312C Organic compounds
12/03/2013CA2599411C Enzyme inhibitors
12/03/2013CA2570987C Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/2013
11/28/2013WO2013177559A2 Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
11/28/2013WO2013176698A1 Carboline and carbazole based imaging agents for detecting neurological dysfunction
11/28/2013WO2013175206A1 Novel compounds
11/28/2013WO2013174645A1 N-thio-anthranilamide compounds and their use as pesticides
11/28/2013WO2013152065A3 1,8-naphthyridin-2(1h)-one derivatives as cytomegalovirus inhibitors
11/28/2013US20130317213 Hepatitis C Virus Inhibitors
11/28/2013US20130317207 Carboxy x rhodamine analogs
11/28/2013US20130317057 Aldosterone synthase inhibitors
11/28/2013US20130317054 Neuronal nicotinic agonist and methods of use
11/28/2013US20130317035 Novel opioid antagonists
11/28/2013US20130317003 Histone Deacetylase Inhibitors
11/28/2013US20130317002 Fused pyrimidines
11/28/2013US20130316981 Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
11/28/2013US20130315895 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
11/28/2013US20130315827 Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders
11/27/2013EP2666774A1 Beta-lactamase Inhibitors
11/27/2013EP2666768A2 Condensed-cyclic compound and organic light-emitting diode comprising the same
11/27/2013EP2665727A1 Bicyclic carboxamide inhibitors of kinases
11/27/2013EP2665725A1 Bicyclic inhibitors of alk
11/27/2013EP2665724A1 Bicyclic inhibitors of alk
11/27/2013EP2665709A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
11/27/2013EP2665706A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
11/27/2013EP2665704A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
11/27/2013CN103415517A Thiocyanato or isothiocyanato substituted naphthalene diimide and rylene diimide compounds and their use as n-type semiconductors
11/27/2013CN103415516A Bicyclic inhibitors of ALK
11/27/2013CN103415515A Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
11/27/2013CN103415504A 2-acyloxy-pyrrolin-4-ones
11/27/2013CN103415289A Pro-neurogenic compounds
11/27/2013CN103408559A Camptothecin and rapid synthesis method of derivative of camptothecin
11/27/2013CN103408545A Preparation method of Stellarine A
11/27/2013CN103405431A Opioid and opioid-like compounds and uses thereof
11/27/2013CN101952287B Protein kinase inhibitors and use thereof
11/27/2013CN101679410B 2-[(2-substituted)-ind0lizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents
11/26/2013US8592424 Topical regional neuro-affective therapy
11/26/2013US8592421 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
11/26/2013US8592395 Therapeutic compounds
11/26/2013US8592057 Organic electroluminescence element, new compound for the same, display device and lighting device using the same
11/26/2013US8590233 Stacking wall panel system and methods of installation and use
11/21/2013WO2013171712A1 Substituted 3, 4 - dihydro - 2h - pyrido [1, 2 -a] pyrazine - 1, 6 - dione derivatives useful for the treatment of (inter alia) alzheimer's disease
11/21/2013WO2013171640A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013170774A1 Acetylene derivative having antineoplastic activity
11/21/2013WO2013170770A1 Acetylene derivatives having antitumor activity
11/21/2013US20130310563 Process for preparing methyl methylcarbamate and its purification for use as pharmaceutically active compound
11/21/2013US20130310562 Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors
11/21/2013US20130310418 Azaindazoles useful as inhibitors of kinases
11/21/2013US20130310417 Small Molecules For Endothelial Cell Activation
11/21/2013US20130310393 Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators
11/21/2013US20130310391 7-azaindole derivatives
11/21/2013US20130310379 Modulators of methyl modifying enzymes, compositions and uses thereof
11/21/2013US20130310374 Substituted Imidazoquinoline Derivatives
11/21/2013US20130310365 Cyclohexyl-azetidinyl antagonists of ccr2
11/21/2013US20130310364 Compositions and methods for inhibition of the jak pathway
11/21/2013US20130310348 Quinoline derivatives and uses thereof
11/21/2013US20130310320 Boronic ester and acid compounds, synthesis and uses
11/21/2013US20130309200 Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors
11/21/2013US20130309197 Inhibitors of cytochrome p450
11/21/2013US20130309191 Compounds for the treatment of clostridium difficile-associated disease
11/20/2013EP2664618A2 Chemokine receptor modulators
11/20/2013EP2663565A2 Heteroaryl compounds and methods of use thereof
11/20/2013EP2663564A1 Imidazo [4, 5 -c]quinolin- 2 -one compound and its use as pi3 kinase / mtor dual inhibitor
11/20/2013EP2663559A1 Oxazine derivatives and their use in the treatment of neurological disorders
11/20/2013EP2531501B1 Apoptosis signal-regulating kinase 1 inhibitors
11/20/2013EP2519521B1 Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
11/20/2013EP2451810B1 Continuous flow process for the preparation of sulphoxide compounds
11/20/2013EP2430022B1 1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
11/20/2013EP2334672B1 4,5,6,7-Tetrahydroimidazo[4,5-c]pyridine compounds as inhibitors of SSAO
11/20/2013EP2285808B1 Spiro-indole derivatives for the treatment of parasitic diseases
11/20/2013EP2146572B1 Bicyclic anilide heterocyclic cgrp receptor antagonists
11/20/2013EP2091943B1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
11/20/2013EP2086972B1 Compounds modulating c-fms and/or c-kit activity and uses therefor
11/20/2013EP1915372B1 Indole derivatives as crth2 receptor antagonists
11/20/2013EP1881982B1 Imidazolone phenylalanine derivatives as vla-4 antagonists
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 646